Medication Overuse Headache
26
4
4
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
1 terminated out of 26 trials
93.3%
+6.8% vs benchmark
12%
3 trials in Phase 3/4
29%
4 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (26)
i-NEED: NEw migrainE Drugs Database
Greater Occipital Nerve Block for Migraine With Medication Overuse Headache
Non-Invasive Brain Stimulation as Add-on Treatment in Chronic Migraine With Medication Overuse
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
Personalized Pulsed Radiofrequency of the Greater Occipital Nerve for Medication Overuse Headache
China HeadAche DIsorders RegiStry
Efficacy and Central Mechanisms of Electroacupuncture for Medication Overuse Headache
Mindfulness Therapy for Chronic Migraine
Biofeedback-VR for Treatment of Chronic Migraine
Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment
Eptinezumab in Adults With Migraine and Medication Overuse Headache
Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy
Medication-overuse Headache: 4 Years Follow up
Is Detoxification Needed in Medication-overuse Headache?
Anodal tDCS in Chronic Migraine With Medication Overuse
tDCS in Chronic Migraine With Medication Overuse (Edisom)
Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches
An Observation Study on Neuropsychology and Serum Melatonin Level in Patients With Medication Overuse Headache
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
Pilot Study of DFN-11 Injection in Medication Overuse Headache